TerminatedPhase 2

Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

NCT01690195

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Site Reference ID/Investigator# 84185

Long Beach, California, United States

+38 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2012-09
Enrollment: 343 participants
Sponsor: AbbVie (prior sponsor, Abbott)
Purpose: treatment

Locations (39)

Site Reference ID/Investigator# 84185Long Beach, California, United States
Site Reference ID/Investigator# 84183San Francisco, California, United States
Site Reference ID/Investigator# 84187Hamden, Connecticut, United States
Site Reference ID/Investigator# 84178Delray Beach, Florida, United States
Site Reference ID/Investigator# 84180Orlando, Florida, United States
Site Reference ID/Investigator# 84186West Palm Beach, Florida, United States
Site Reference ID/Investigator# 84182Elk Grove Village, Illinois, United States
Site Reference ID/Investigator# 84181Staten Island, New York, United States
Site Reference ID/Investigator# 84179Bennington, Vermont, United States
Site Reference ID/Investigator# 84173Gatineau, Canada
Site Reference ID/Investigator# 84174Montreal, Canada
Site Reference ID/Investigator# 84177Peterborough, Canada
Site Reference ID/Investigator# 84175Toronto, Canada
Site Reference ID/Investigator# 84176Verdun, Canada
Site Reference ID/Investigator# 84376Dijon, France
Site Reference ID/Investigator# 84373Limoges, France
Site Reference ID/Investigator# 84377Paris, France
Site Reference ID/Investigator# 84374Paris, France
Site Reference ID/Investigator# 84375Toulouse, France
Site Reference ID/Investigator# 84382Berlin, Germany
Site Reference ID/Investigator# 84380Freiburg im Breisgau, Germany
Site Reference ID/Investigator# 84383Hüttenberg, Germany
Site Reference ID/Investigator# 84379Mittweida, Germany
Site Reference ID/Investigator# 84381Munich, Germany
Site Reference ID/Investigator# 84378Schwerin, Germany
Site Reference ID/Investigator# 84385Athens, Greece
Site Reference ID/Investigator# 84388Athens, Greece
Site Reference ID/Investigator# 84389Athens, Greece
Site Reference ID/Investigator# 84386Haidari, Athens, Greece
Site Reference ID/Investigator# 84390Thessaloniki, Greece
Site Reference ID/Investigator# 84395Belville, South Africa
Site Reference ID/Investigator# 84391Cape Town, South Africa
Site Reference ID/Investigator# 84393George, South Africa
Site Reference ID/Investigator# 84394Johannesburg, South Africa
Site Reference ID/Investigator# 84392Rosebank, South Africa
Site Reference ID/Investigator# 84398Bath, United Kingdom
Site Reference ID/Investigator# 84397Glasgow, United Kingdom
Site Reference ID/Investigator# 84400London, United Kingdom
Site Reference ID/Investigator# 84399Manchester, United Kingdom